HUTCHMED (China) (HMDCF) Gross Margin Growth (5y) (2020)
Powered by 
Analysis
HUTCHMED (China) (HMDCF) Gross Margin Growth (5y) (2020) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.40 Bn | 197.42 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 181.20 Bn | 178.03 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.13 Bn | 124.28 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.53 Bn | 74.53 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.72 Bn | 56.54 Bn | 1.37 Bn |
| 6 | Moderna | 54.67 Bn | 49.53 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.13 Bn | 30.82 Bn | 992.69 Mn |
| 8 | Biogen | 31.29 Bn | 30.00 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.03 Bn | 30.03 Bn | 1.16 Mn |
| 10 | HUTCHMED (China) | 376.85 Mn | 391.04 Mn | - |